Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» CDMOs
CDMOs
High-flying Fujifilm splashes $200M to beef up cell therapy capacity
High-flying Fujifilm splashes $200M to beef up cell therapy capacity
Fierce Pharma
Fujifilm
CDMOs
cell therapy
Flag link:
J&J books manufacturing space at Fujifilm Diosynth's upcoming mega-plant in North Carolina
J&J books manufacturing space at Fujifilm Diosynth's upcoming mega-plant in North Carolina
Fierce Pharma
JNJ
Janssen
Fujifilm Diosynth Biotechnologies
CDMOs
North Carolina
Flag link:
Lonza expands antibody-drug conjugate production pact, plots 180 new hires
Lonza expands antibody-drug conjugate production pact, plots 180 new hires
Fierce Pharma
Lonza
CDMOs
hirings
bioconjugation
Flag link:
Bluebird taps Lonza to boost manufacturing capacity for its gene therapies Zynteglo, Skysona
Bluebird taps Lonza to boost manufacturing capacity for its gene therapies Zynteglo, Skysona
Fierce Pharma
Bluebird Bio
gene therapy
Lonza
drug manufacturing
CDMOs
Flag link:
Advent International and Warburg Pincus Name Franco Negron CEO of BioPharma Solutions Following its Proposed Divestiture from Baxter
Advent International and Warburg Pincus Name Franco Negron CEO of BioPharma Solutions Following its Proposed Divestiture from Baxter
Yahoo/PR Newswire
BioPharma Solutions
Baxter International
CDMOs
Franco Negron
Flag link:
Emergent to lay off 400 staffers, eliminate executive position in pivot away from contract manufacturing
Emergent to lay off 400 staffers, eliminate executive position in pivot away from contract manufacturing
Fierce Pharma
Emergent BioSolutions
CDMOs
Narcan
layoffs
Flag link:
Catalent Delays Earnings Call, Shaves $400M Off FY23 Guidance
Catalent Delays Earnings Call, Shaves $400M Off FY23 Guidance
BioSpace
Catalent
earnings
CDMOs
Flag link:
Danaher backs away from Catalent as CDMO struggles with productivity problems: report
Danaher backs away from Catalent as CDMO struggles with productivity problems: report
Fierce Pharma
Catalent
Danaher
M&A
CDMOs
Flag link:
PharmaBlock Receives 2023 ACS CMO Excellence in Green Chemistry Award
PharmaBlock Receives 2023 ACS CMO Excellence in Green Chemistry Award
CP Wire
PharmaBlock
CDMOs
sustainability
Flag link:
PharmaBlock Receives 2023 ACS CMO Excellence in Green Chemistry Award
PharmaBlock
CDMOs
sustainability
Flag link:
PharmaBlock Opens New R&D Facility in Pennsylvania ——Expanding Capacity to Deliver GMP Projects
PharmaBlock Opens New R&D Facility in Pennsylvania ——Expanding Capacity to Deliver GMP Projects
CP Wire
PharmaBlock
R&D
Pennsylvania
CDMOs
Flag link:
PharmaBlock Opens New R&D Facility in Pennsylvania ——Expanding Capacity to Deliver GMP Projects
PharmaBlock
R&D
Pennsylvania
CDMOs
Flag link:
Medtech CDMO sector poised for M&A rebound in 2023 amid ‘attractive’ targets: report
Medtech CDMO sector poised for M&A rebound in 2023 amid ‘attractive’ targets: report
Medtech Dive
Medtech
M&A
CDMOs
Flag link:
Samsung Biologics spells out expansion plans in South Korea and US
Samsung Biologics spells out expansion plans in South Korea and US
Endpoints
Samsung BioLogics
South Korea
CDMOs
Flag link:
In flux, CDMO Abzena lays off 66 in San Diego days after hiring new CEO and reshuffling board
In flux, CDMO Abzena lays off 66 in San Diego days after hiring new CEO and reshuffling board
Fierce Pharma
Abzena
CDMOs
layoffs
antibody-drug conjugate
Flag link:
Three Ohio-based contract organizations win $149M deal for neurological candidates
Three Ohio-based contract organizations win $149M deal for neurological candidates
Endpoints
CDMOs
Battelle
AmplifyBio
Andelyn Biosciences
neurological disorders
Flag link:
Sarepta marches forward with its potential DMD gene therapy and an expanded Catalent manufacturing deal
Sarepta marches forward with its potential DMD gene therapy and an expanded Catalent manufacturing deal
Endpoints
Sarepta Therapeutics
SRP-9001
gene therapy
Duchenne Muscular Dystrophy
CDMOs
Catalent
Flag link:
Delpharm acquires injectable drug development center in the Netherlands from Dr Reddy's
Delpharm acquires injectable drug development center in the Netherlands from Dr Reddy's
Biopharma Reporter
Delpharm
CDMOs
drug development
The Netherlands
Dr Reddy's
Flag link:
Fujifilm to build $188M manufacturing plant in North Carolina’s research triangle
Fujifilm to build $188M manufacturing plant in North Carolina’s research triangle
Endpoints
Fujifilm
CDMOs
North Carolina
drug manufacturing
RTP
Flag link:
NovaQuest Private Equity Announces Investment In Bend Bioscience to Broaden CoreRx Offering
NovaQuest Private Equity Announces Investment In Bend Bioscience to Broaden CoreRx Offering
CP WIre
Bend Biosciences
CoreRx
Novaquest
CDMOs
R&D
drug manufacturing
Flag link:
Pages
1
2
3
4
5
next ›
last »